Scott A Ness Selected Research

Biomarkers (Surrogate Marker)

2/2023	Dominant Gene Expression Profiles Define Adenoid Cystic Carcinoma (ACC) from Different Tissues: Validation of a Gene Signature Classifier for Poor Survival in Salivary Gland ACC.
1/2019	Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
1/2017	Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.
1/2011	Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott A Ness Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 01/2003
4	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2017
3	Adenoid Cystic Carcinoma (Cylindroma) 08/2020 - 02/2016
3	Leukemia 06/2019 - 03/2008
2	Genetic Translocation (Chromosomal Translocation) 08/2020 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2019 - 01/2017
2	Carcinogenesis 10/2014 - 12/2008
1	Circulating Neoplastic Cells 11/2023
1	Ascites 01/2023
1	Inflammation (Inflammations) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Acinar Cell Carcinoma 08/2020
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Adenocarcinoma 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Residual Neoplasm 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 12/2008
1	Disease Progression 12/2008
1	Lymphoma (Lymphomas) 03/2008
1	Thrombosis (Thrombus) 04/2006
1	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2004

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 11/2023 - 04/2006
5	Transcription Factors (Transcription Factor)IBA 02/2023 - 03/2008
4	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
2	CytokinesIBA 01/2023 - 06/2019
2	Formaldehyde (Formol)FDA Link 01/2019 - 01/2018
2	ParaffinIBA 01/2019 - 01/2018
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 08/2020
1	Orphan Nuclear ReceptorsIBA 08/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	ruxolitinibIBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2011
1	ChromatinIBA 01/2011
1	Proto-Oncogene Proteins c-mybIBA 01/2011
1	Testosterone (Sustanon)FDA Link 12/2008
1	Dihydrotestosterone (Androstanolone)IBA 12/2008
1	AndrogensIBA 12/2008
1	EnzymesIBA 12/2008
1	SteroidsIBA 12/2008
1	Messenger RNA (mRNA)IBA 04/2006
1	Complementary DNA (cDNA)IBA 04/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2006
1	Glycoproteins (Glycoprotein)IBA 04/2006
1	Thromboplastin (Tissue Factor)IBA 04/2006
1	beta CateninIBA 03/2004
1	Cadherins (E-Cadherin)IBA 03/2004
1	polycystic kidney disease 1 proteinIBA 03/2004
1	polycystic kidney disease 2 proteinIBA 03/2004

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2017
1	Immunotherapy 01/2023
1	Neoadjuvant Therapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2017